Bioadhesive polymers, permeation enhancers and types of dosage forms for buccal drug delivery

  • Kumara Swamy Samanthula Vaagdevi Pharmacy College, Bollikunta, Warangal, India
  • Shobha Rani Satla Centre for Pharmaceutical Sciences, IST, JNTU, Kukatpally, Hyderabad, India
  • Agaiah Goud Bairi SRR College of Pharmaceutical Sciences, Valbhapur, Warangal, India

Abstract

The buccal delivery is defined as the drug administration through the mucosal membranes lining the cheeks (buccal mucosa). The main impediment to the use of many hydrophilic macromolecular drugs as potential therapeutic agents is their inadequate and erratic oral absorption. Based on our current understanding of biochemical and physiological aspects of absorption and metabolism of many biotechnologically produced drugs, they cannot be delivered effectively through the conventional oral route. Because after oral administration many drugs are subjected to pre-systemic clearance extensive in the liver, which often leads to a lack of significant correlation between membrane permeability, absorption and bioavailability. Difficulties associated with the parenteral delivery and poor oral bioavailability provided the impetus for exploring alternative routes for the delivery of such drugs. This review covers the advantages, disadvantages of buccal delivery, drug and excipient selection especially bioadhesive polymers and permeation enhancers, and further a list of drugs developed as various dosage forms for buccal route of administration.


Keywords: Buccal delivery, bioadhesive/mucoadhesive, permeation enhancer, dosage forms.

Keywords: Buccal delivery, bioadhesive/mucoadhesive, permeation enhancer, dosage forms

Downloads

Download data is not yet available.

Author Biographies

Kumara Swamy Samanthula, Vaagdevi Pharmacy College, Bollikunta, Warangal, India

Vaagdevi Pharmacy College, Bollikunta, Warangal, India

Shobha Rani Satla, Centre for Pharmaceutical Sciences, IST, JNTU, Kukatpally, Hyderabad, India

Centre for Pharmaceutical Sciences, IST, JNTU, Kukatpally, Hyderabad, India

Agaiah Goud Bairi, SRR College of Pharmaceutical Sciences, Valbhapur, Warangal, India

SRR College of Pharmaceutical Sciences, Valbhapur, Warangal, India

References

1. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery–a review. Pharmaceutical science & technology today. 2000 Apr 1; 3(4):138-45.
2. Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability. Therapeutic delivery. 2017 Feb; 8(2):79-88.
3. Dudhipala N. Enhancement of Solubility and Dissolution Rate of Trandolapril Sustained Release Matrix Tablets by Liquisolid Compact Approach. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2015 Nov 24; 9(4).
4. Doodipala NR, Sunil R, Rao M. Development of floating matrix tablets of Ofloxacin and Ornidazole in combined dosage form: in vitro and in vivo evaluation in healthy human volunteers. International Journal of Drug Delivery. 2012 Oct 1; 4(4):462.
5. Thirupathi G, Swetha E, Narendar D. Role of isradipine loaded solid lipid nanoparticles on the pharmacodynamic effect in rats. Drug research. 2017 Mar; 67(03):163-9.
6. Doodipala N, Palem C, Reddy S, Rao Y. Pharmaceutical development and clinical pharmacokinetic evaluation of gastroretentive floating matrix tablets of levofloxacin. Int J Pharm Sci Nanotech. 2011; 4(3):1461-7.
7. Janga KY, Tatke A, Dudhipala N, Balguri SP, Ibrahim MM, Maria DN, Jablonski MM, Majumdar S. Gellan gum based sol-to-gel transforming system of natamycin transfersomes improves topical ocular delivery. Journal of Pharmacology and Experimental Therapeutics. 2019 Sep 1; 370(3):814-22.
8. Mahipalreddy D, Narendar D, Devendhar K, Dinesh S, Kiran S, Nagaraj B. Preparation and evaluation of ketoprofen enteric coated mini tablets for prevention of chronic inflammatory disease. J Pharm Drug Deliv Res. 2015; 4(2).
9. Dudhipala N. A review of novel formulation strategies to enhance oral delivery of zaleplon. J Bioequiv Availab. 2016; 8:211-3.
10. Ahuja A, Khar RK, Ali J. Mucoadhesive drug delivery systems. Drug DevInd Pharm. 1997; 23(5):489–517.
11. Dudhipala N, Youssef AA, Banala N. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application. Chemistry and Physics of Lipids. 2020 Nov 1; 233:104981.
12. Bremecker K.D., Strempel H., Klein G., 1984. Novel concept for a mucosal adhesive ointment. J.Pharm.Sci, 73, 548-552.
13. Dudhipala N, Phasha Mohammed R, Adel Ali Youssef A, Banala N. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation. Drug Development and Industrial Pharmacy. 2020 Aug 2; 46(8):1334-44.
14. Ch’ng HS, Park H, Kelly P, Robinson JR. Bioadhesivepolymers as platforms for oral controlled drug delivery: II.Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci. 1985; 74:399– 405.
15. Palem CR, Dudhipala N, Battu SK, Goda S, Repka MA, Yamsani MR. Combined dosage form of pioglitazone and felodipine as mucoadhesive pellets via hot melt extrusion for improved buccal delivery with application of quality by design approach. Journal of Drug Delivery Science and Technology. 2015 Dec 1; 30:209-19.
16. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998; 1(1):15–30.
17. Dudhipala N, Narala A, Bomma R. Recent updates in the formulation strategies to enhance the bioavailability of drugs administered via intranasal route. JBB, An Open Access Journal. 2016; 8(5):204-7.
18. Schenkels L, Gururaja TL, Levine MJ, in: Rathbone MJ (Ed.), Oral Mucosal Drug Delivery, Marcel Dekker, New York, 1996; 191–220.
19. Dudhipala N. A Comprehensive Review on Solid Lipid Nanoparticles as Delivery Vehicle for Enhanced Pharmacokinetic and Pharmacodynamic Activity of Poorly Soluble Drugs. Int. J. Pharm. Sci. Nanotechnol. 2019; 12:4421-40.
20. Swamy SK, Reddy LN, Goud BA. Development and in vitro evaluation of bioadhesive buccal tablets of hydralazine hydrochloride. Int. J. Pharm. Educ. Res.. 2014; 1:8-16.
21. Save T, Shah MU, Ghamande AR, Venkitachalam P. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine. J Pharm Pharmacol. 1994; 46:192– 195.
22. Goud BA, Swamy K, Kumar P. Formulation and evaluation of bioadhesive buccal tablets of simvastatin. Journal of Advanced Pharmaceutical Sciences. 2011; 1(1):29-38.
23. Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug delivery. 2016 Feb 12; 23(2):395-404.
24. Rathbone MJ, Ponchel G, Ghazali FA. Systemic and oral mucosaldrug delivery and delivery systems, in: M.J. Rathbone (Ed.), OralMucosal Drug Delivery, Marcel Dekker Inc., New York, 1996; 74:241–284.
25. Hao J, Heng PW. Buccal delivery systems. Drug development and industrial pharmacy. 2003 Jan 1; 29(8):821-32.
26. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. International journal of pharmaceutics. 1984 Apr 1; 19(2):107-27.
27. Lueßen HL, Lehr CM, Rentel CO, Noach AB, De Boer AG, Verhoef JC, Junginger HE. Bioadhesive polymers for the peroral delivery of peptide drugs. Journal of Controlled Release. 1994 Mar 1; 29(3):329-38.
28. Dudhipala N, Gorre T. Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson’s Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation. Pharmaceutics. 2020 May; 12(5):448.
29. Kumar K, Dhawan N, Sharma H, Vaidya S, Vaidya B. Bioadhesive polymers: novel tool for drug delivery. Artificial cells, nanomedicine, and biotechnology. 2014 Aug 1; 42(4):274-83.
30. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. International journal of pharmaceutics. 2003 Apr 14; 255(1-2):13-32.
31. Harris D, Robinson JR. Bioadhesive polymers in peptide drug delivery. Biomaterials. 1990 Nov 1; 11(9):652-8.
32. Dudhipala N, Narala A, Janga KY, Bomma R. Amoxycillin trihydrate floating-bioadhesive drug delivery system for eradication of helicobacter pylori: preparation, in vitro and ex vivo evaluation. J Bioequiv Availab. 2016; 8(3):118-24.
33. Narendar D, Arjun N, Someshwar K, Rao YM. Quality by design approach for development and optimization of Quetiapine Fumarate effervescent floating matrix tablets for improved oral bioavailability. Journal of Pharmaceutical Investigation. 2016 Jun 1; 46(3):253-63.
34. Donthi MR, Dudipala N, Komalla DR, Suram D, Banala N. Design and Evaluation of Floating Multi Unit Mini Tablets (MUMTS) Muco Adhesive Drug Delivery System of Famotidine to Treat Upper Gastro Intestinal Ulcers. Journal of Pharmacovigilance. 2015 Oct 12.
35. Pitta SK, Dudhipala N, Narala A, Veerabrahma K. Development of zolmitriptan transfersomes by Box–Behnken design for nasal delivery: in vitro and in vivo evaluation. Drug development and industrial pharmacy. 2018 Mar 4; 44(3):484-92.
36. Shruthi K, Narendar D, Arjun N, Kishan V. Development and Antimicrobial Evaluation of Binary Ethosomal Topical Gel of Terbinafine Hydrochloride for the Treatment of Onychomycosis. Int. J. Pharm. Sci. Nanotechnol. 2018; 11:3998-4005.
37. Nagaraj B, Anusha K, Narendar D, Sushma P. Formulation and evaluation of microemulsion-based transdermal delivery of duloxetine hydrochloride. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020 Jan 31; 13(1):4773-82.
38. Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expert opinion on drug delivery. 2010 Jan 1; 7(1):97-112.
39. Padula C, Pescina S, Nicoli S, Santi P. New insights on the mechanism of fatty acids as buccal permeation enhancers. Pharmaceutics. 2018 Dec; 10(4):201.
40. Arjun N, Narendar D, Sunitha K, Harika K, Nagaraj B. Development, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol. International journal of pharmaceutical investigation. 2016 Oct; 6(4):238.
41. Samanthula KS, Satla SR, Bairi AG. Development, In-Vitro and Ex-Vivo Evaluation of Muco-adhesive Buccal patches of Candesartan cilexetil. Research Journal of Pharmacy and Technology. 2019; 12(6):3038-44.
42. Nagaraj B. Development of Osmotically Controlled Oral Drug Delivery Systems of Tramadol Hydrochloride: Effect of Formulation Variables on In Vitro Release Kinetics. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2016 Sep 10; 10(03).
43. Junginger HE, Hoogstraate JA, Verhoef JC. Recent advances in buccal drug delivery and absorption—in vitro and in vivo studies. Journal of controlled release. 1999 Nov 1; 62(1-2):149-59.
44. Dudhipala N, Veerabrahma K. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug development and industrial pharmacy. 2015 Dec 2; 41(12):1968-77.
45. Aungst BJ. Absorption enhancers: applications and advances. The AAPS journal. 2012 Mar 1; 14(1):10-8.
46. Dudhipala N, Janga KY, Gorre T. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Artificial cells, nanomedicine, and biotechnology. 2018 Nov 5; 46(sup2):616-25.
47. Nagai T, Machida Y. Buccal delivery systems using hydrogels. Advanced drug delivery reviews. 1993 Jul 1; 11(1-2):179-91.
48. Şenel S, Hıncal AA. Drug permeation enhancement via buccal route: possibilities and limitations. Journal of Controlled Release. 2001 May 14; 72(1-3):133-44.
49. Krishna VM, Kumar VB, Dudhipala N. In-situ intestinal absorption and pharmacokinetic investigations of carvedilol loaded supersaturated self-emulsifying drug system. Pharmaceutical nanotechnology. 2020 Jun 1; 8(3):207-24.
50. Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers—how do they really work?. Journal of controlled release. 2005 Jun 20; 105(1-2):1-5.
51. Nagaraj K, Narendar D, Kishan V. Development of olmesartan medoxomil optimized nanosuspension using the Box–Behnken design to improve oral bioavailability. Drug Development and Industrial Pharmacy. 2017 Jul 3; 43(7):1186-96.
52. Rossi S, Sandri G, Caramella CM. Buccal drug delivery: a challenge already won?. Drug Discovery Today: Technologies. 2005 Mar 1; 2(1):59-65.
53. Esim O, Savaser A, Ozkan CK, Bayrak Z, Tas C, Ozkan Y. Effect of polymer type on characteristics of buccal tablets using factorial design. Saudi Pharmaceutical Journal. 2018 Jan 1; 26(1):53-63.
54. Le ND, Tran PH, Lee BJ, Tran TT. Solid lipid particle-based tablets for buccal delivery: the role of solid lipid particles in drug release. Journal of Drug Delivery Science and Technology. 2019 Aug 1; 52:96-102.
55. Dudhipala N, Veerabrahma K. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 2017 Jan 1; 110:47-57.
56. Ventouras K, inventor; Novartis Consumer Health SA, assignee. Buccal delivery system. United States patent US 6,183,775. 2001 Feb 6.
57. Akbari J, Nokhodchi A, Farid D, Adrangui M, Siahi-Shadbad MR, Saeedi M. Development and evaluation of buccoadhesivepropranolol hydrochloride tablet formulations: Effect of fillers, IL Farmaco. 2004; 59:155– 161.
58. Chopparapu C, Palem CR, Yamsani MR. Development of Promethazine mucoadhesive tablets for buccal delivery: in-vitro, ex-vivo and in-vivo characterization. American Jr PharmTech Res. 2012; 2(1):1697-705.
59. Boyapally H, Nukala RK, Bhujbal P, Douroumis D. Controlled release from directly compressible theophylline buccal tablets. Colloids and Surfaces B: Biointerfaces. 2010 Jun 1; 77(2):227-33.
60. Gowthamarajan K, Jawahar N, Wake P, Jain K, Sood S. Development of buccal tablets for curcumin using Anacardium occidentale gum. Carbohydrate Polymers. 2012 May 16; 88(4):1177-83.
61. Varshosaz J, Dehghan Z. Development and characterizationof buccoadhesive nifedipine tablets. Eur J Pharm Biopharm. 2002; 54:135– 141.
62. Banala N, Peddapalli H, Dudhipala N, Chinnala KM. Transmucosal Delivery of Duloxetine Hydrochloride for Prolonged Release: Preparation, in vitro, ex vivo Characteri-zation and in vitro-ex vivo Correlation. International Journal of Pharmaceutical Sciences and Nanotechnology. 2018 Sep 30; 11(5):4249-58.
63. Mohammed FA, Khedr H. Preparation and in vitro/in vivoevaluation of the buccal bioadhesive properties of slow release tablets containing miconazole nitrate. Drug DevInd Pharm. 2003; 29:321–337.
64. Luana periolia, Valeria Ambrogia, Fausta Angelicia, Maurizio Riccia, Stefano Giovanolia, Marinella Giovanolia, Marinella Capuccellab, Carlo Rossia. Development of mucoadhesive patches for buccal administration of ibuprofen. J Contro Release. 2004; 99:73-82.
65. Guo JH. Investigating the surface properties and bioadhesion of buccal patches. Journal of pharmacy and pharmacology. 1994 Aug; 46(8):647-50.
66. Shirvan AR, Bashari A, Hemmatinejad N. New insight into the fabrication of smart mucoadhesive buccal patches as a novel controlled-drug delivery system. European Polymer Journal. 2019 Oct 1; 119:541-50.
67. Palem CR, Gannu R, Doodipala N, Yamsani VV, Yamsani MR. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization. Archives of pharmacal research. 2011 Oct 1; 34(10):1701-10.
68. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. International Journal of Pharmaceutics. 2003 Oct 2; 264(1-2):1-4.
69. Shidhaye SS, Saindane NS, Sutar S, Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate. Aaps Pharmscitech. 2008 Sep 1; 9(3):909-16.
70. Vamshi Vishnu Y, Chandrasekhar K, Ramesh G, Madhusudan Rao Y. Development of mucoadhesive patches for buccal administration of carvedilol. Current drug delivery. 2007 Jan 1; 4(1):27-39.
71. Shiledar RR, Tagalpallewar AA, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydrate polymers. 2014 Jan 30; 101:1234-42.
72. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. European Journal of Pharmaceutics and Biopharmaceutics. 2011 Feb 1; 77(2):187-99.
73. Montenegro-Nicolini M, Morales JO. Overview and future potential of buccal mucoadhesive films as drug delivery systems for biologics. AAPS PharmSciTech. 2017 Jan 1; 18(1):3-14.
74. Palem CR, Dudhipala NR, Battu SK, Repka MA, Rao Yamsani M. Development, optimization and in vivo characterization of domperidone-controlled release hot-melt-extruded films for buccal delivery. Drug development and industrial pharmacy. 2016 Mar 3; 42(3):473-84.
75. Ritschel WA, Ritschel GB, Forusz H, Kraeling M. Buccal absorption of insulin in the dog. Res Commun Chem Pathol Pharmacol. 1989; 63:53– 67.
76. Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: in vitro/in vivo performance. Current drug delivery. 2009 Jan 1; 6(1):17-27.
77. Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug delivery. 2016 Feb 12; 23(2):471-8.
78. Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Frontiers in Pharmacology. 2019; 10.
79. Smart JD. Buccal drug delivery. Expert opinion on drug delivery. 2005 May 1; 2(3):507-17.
80. Marques AC, Rocha AI, Leal P, Estanqueiro M, Lobo JM. Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen. International Journal of Pharmaceutics. 2017 Nov 30; 533(2):455-62.
81. Tsutsumi K, Obata Y, Nagai T, Loftsson T, Takayama K. Buccal absorption of ergotamine tartrate using the bioadhesivetablet system in guinea-pigs. Int J Pharm. 2002; 238:161–170.
82. Cassidy J, Berner B, Chan K, John V, Toon S, Holt B, Rowland M. Human transbuccal absorption of diclofenacsodium from a prototype hydrogel delivery device. Pharm Res. 1993; 10:126– 129.
83. Shin SC, Bum JP, Choi JS. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. International journal of pharmaceutics. 2000 Nov 19; 209(1-2):37-43.
84. Tan YTF, Peh KK, Al-Hanbali O. Effect of Carbopol andpolyvinylpyrrolidone on the mechanical, rheological, andrelease properties of bioadhesive polyethylene glycol gels. AAPS PharmSciTech. 2000; 1:E24.
85. Cid YP, Pedrazzi V, de Sousa VP, Pierre MB. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. AAPS PharmSciTech. 2012 Mar 1; 13(1):101-11.
86. De Vries ME, Bodde HE, Busscher HJ, Junginger HE. Hydrogels for buccal drug delivery: Properties relevant for muco‐adhesion. Journal of biomedical materials research. 1988 Nov; 22(11):1023-32.
87. Butreddy A, Narala A, Dudhipala N. Formulation and characterization of Liquid Crystalline Hydrogel of Agomelatin: In vitro and Ex vivo evaluation. Journal of Applied Pharmaceutical Science. 2015 Sep; 5(09):110-4.
88. Xu J, Strandman S, Zhu JX, Barralet J, Cerruti M. Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery. Biomaterials. 2015 Jan 1; 37:395-404.
Statistics
266 Views | 238 Downloads
How to Cite
1.
Samanthula KS, Satla SR, Bairi AG. Bioadhesive polymers, permeation enhancers and types of dosage forms for buccal drug delivery. JDDT [Internet]. 15Jan.2021 [cited 28Sep.2021];11(1):138-45. Available from: https://jddtonline.info/index.php/jddt/article/view/4495